SESSION 39 SCHEDULE
Sunday
SESSION 39: NEW DEVELOPMENTS, TECHNIQUES AND CONCEPTS (5-MINUTE TALKS)
xxxx
Moderators:TBD
x
6:45 AM - 6:50 AM What Proportion Of AAAs Can Be Treated With Current Endografts?
 
6:51 AM - 6:56 AM Use Of Duplex Imaging To Detect Common Femoral Artery Injuries During EVAR
 
6:57 AM - 7:02 AM Tips And Tricks In The Endovascular Treatment Of Large A-V Fistulas
 
7:03 AM - 7:08 AM Virtual Angioscopy Of The Thoracic And Abdominal Aorta: Is It A Useful Tool Or A Fancy Toy?
 
7:09 AM - 7:14 AM Tips And Tricks To Make TIPS Procedures Effective Using Stent-Grafts
 
7:15 AM - 7:20 AM How To Use Clopidigrel (Plavix) To Make CEA Safer
 
7:21 AM - 7:26 AM Panel Discussion
Moderator(s): TBD / TBD  
7:26 AM - 7:31 AM Myths And Little Known Facts About Collateral Development With Major Arterial Occlusion
 
7:32 AM - 7:37 AM Minimally Invasive Approach To Treat The Median Arcuate Ligament Syndrome: Technique And Results
 
7:38 AM - 7:43 AM Chronic Lymphedema: How Best To Treat It: Are There Still Surgical Options?
 
7:44 AM - 7:49 AM Technical Tips For Crossing Long Tibial Occlusions
 
7:50 AM - 7:55 AM Are Reentry Devices Necessary When Crossing Most Long Totally Occluded Segments?
 
7:56 AM - 8:01 AM New Developments And Updated Results With Duplex Guided PTA And Stenting
 
8:02 AM - 8:08 AM Panel Discussion
END OF SESSION 39
 
SESSION 40 SCHEDULE
Sunday
SESSION 40: MORE ABOUT THORACIC AND ABDOMINAL ANEURYSMS (5-MINUTE TALKS)
xxxx
Moderators:TBD
x
8:08 AM - 8:13 AM 10-Year Results After EVAR vs. 10-Year Results After Open Repair
 
8:14 AM - 8:19 AM Updated Data On Safety Of Bilateral Hypogastric Interruption With EVAR And OR: Cooperative Study In 135 Patients
 
8:20 AM - 8:25 AM Endovascular Treatment Of Iliac Aneurysms Involving The Hypogastric Artery: Concurrent Comparison Of Branched Endografts vs. Hypogastric Occlusion
 
8:26 AM - 8:31 AM Significance Of Mesenteric Arteries During EVAR
 
8:32 AM - 8:37 AM Debate 21: With EVAR Outcomes Are Not Influenced By AAA Size
 
8:38 AM - 8:43 AM Debate 21: With EVAR Outcomes Are Influenced By Size: Big Is Bad
 
8:44 AM - 8:49 AM Can Positron Emission Tomography (PET) Imaging And Biochemical Analysis Help To Predict AAA Rupture?
 
8:50 AM - 8:56 AM Panel Discussion
Moderator(s): TBD / TBD  
8:56 AM - 9:01 AM Technique For Fascial Suture To Close Puncture Sites For Percutaneously Placed Large Sheaths: It Works But It Has To Be Done Right (Video Presentation)
 
9:02 AM - 9:07 AM Tips And Tricks For Improving Results Or Managing Tortuous Or Adverse Neck Anatomy With The Gore Excluder Graft
 
9:08 AM - 9:13 AM New Developments In The Management Of Graft Enteric (Aortoduodenal) Fistulas: Successful In Situ Repair With Silver Impregnated, Rifampin Soaked Grafts
 
9:14 AM - 9:19 AM Advantages And Limitations Of The New Medtronic Valiant Captivia Stent-Graft For TEVAR
  Presenters(s):Matt M. Thompson, MD  
9:20 AM - 9:25 AM Adjuvant Maneuvers To Affect Graft Tilt During EVAR With Angulated Necks: Should We Try To Fit The Aorta To The Graft Or Should We Try To Fit The Graft To The Aorta Ė And How?
 
9:26 AM - 9:31 AM Off-The-Shelf Device For EVAR Treatment Of Juxtarenal Aneurysms
 
9:32 AM - 9:38 AM Panel Discussion
END OF SESSION 40
 
SESSION 41 SCHEDULE
Sunday
SESSION 41: NEW DEVELOPMENTS IN DISEASES OF THE CAROTIDS, VERTEBRALS AND SUPRA-AORTIC TRUNKS (5-MINUTE TALKS)
xxxx
Moderators:TBD
x
9:38 AM - 9:43 AM Debate 22: Covered Stents Are Good For The Treatment Of Carotid Artery Aneurysms
 
9:44 AM - 9:49 AM Debate 22: Endovascular Repair Of Extracranial Carotid Aneurysms Is Still A Hazardous Procedure
 
9:50 AM - 9:55 AM Mortality And Cost Implications For Delaying Treatment After A TIA Or Small Stroke Are Serious: How To Facilitate Early Treatment: The EXPRESS Trial
 
9:56 AM - 10:01 AM Determinants And Late Clinical Significance Of Microemboli With CAS And CEA: When Do They Matter?
 
10:02 AM - 10:07 AM Dos And Doníts Of Endovascular Management Of Carotid Trauma
 
10:07 AM - 10:20 AM Panel Discussion
Moderator(s): TBD / TBD  
10:20 AM - 10:25 AM Routine Shunting vs. Selective Shunting In CEA Based On Stump Pressure: Which Is Best Based On A Randomized Controlled Trial?
 
10:26 AM - 10:31 AM New Portable Multisensor Transducer For Carotid Screening By Non-Specialized Office Personnel
 
10:32 AM - 10:37 AM Update On Population Based Studies Comparing Adverse Event Rates With CAS And CEA In The U.S.: Are CAS Results Improving?
 
10:38 AM - 10:43 AM Diagnosis And Treatment Of Vulnerable Carotid Plaques Causing TIAs Or Strokes: When Should They Be Treated By CEA Or By CAS?
 
10:44 AM - 10:49 AM Tips And Tricks For The Endovascular Treatment Of Subclavian And Innominate Stenosis
 
10:50 AM - 10:55 AM Update On Treatment Of Acute Stroke By IV Thrombolysis And CEA: Why CEA Not CAS: Advantages And Limitations
 
10:56 AM - 11:03 AM Panel Discussion
END OF SESSION 41
 
SESSION 42 SCHEDULE
Sunday
SESSION 42: NEW DEVELOPMENTS IN CAS (4-MINUTE FAST PACED TALKS)
xxxx
Moderators:TBD
x
11:03 AM - 11:07 AM What The Trial And Registry Results To Date Tell Us About The Present Status Of CAS: What Are The Prospects For A Change In This Status In The Future?
 
11:08 AM - 11:12 AM How To Lower Risk Of CAS In Octogenerians And Other High Risk Patients
 
11:13 AM - 11:17 AM Combined Carotid And Coronary Procedures: Nationwide Statistics Show That CAS Has Lower Adverse Events Rates Than CEA
 
11:18 AM - 11:22 AM CAS Experience With Endovascular Flow Interruption Using The MOMA Device: Advantages And Limitations
 
11:23 AM - 11:27 AM Use Of IVUS As An Important Quality Control Technique For CAS: Are There Risks To Its Use?
 
11:28 AM - 11:32 AM Debate 23: Screening To Detect Asymptomatic Carotid Stenosis Is Worthwhile So It Can Be Treated By CAS Or CEA
 
11:33 AM - 11:37 AM Debate 23: Screening To Detect Asymptomatic Carotid Stenosis Is A Bad Thing To Do Except As A Way To Get Patients On Statins: CAS Or CEA In Asymptomatic Patients Consumes Resources But Does Little To Prevent Stroke
 
11:38 AM - 11:42 AM Carotid Interventions For Stroke In Evolution: Indications, Techniques And Results: A 5-Year Experience
 
11:43 AM - 11:47 AM CAS Setbacks: The Plan Was Flawed From The Beginning: Will CAS Recover?
 
11:48 AM - 11:52 AM Carotid Stenting For Radiation Arteritis Has A High Complication And Restenosis Rate
 
11:53 AM - 11:59 AM Panel Discussion
Moderator(s): TBD / TBD  
11:59 AM - 12:03 PM Clinical Course Of Asymptomatic Carotid Stenosis With End-Diastolic Velocity 100-125 cm/sec: Stent Or Observe?
 
12:04 PM - 12:08 PM Technique Of Using An Interruption Of Flow Embolic Protection Device (MOMA) To Make CAS Safer
 
12:09 PM - 12:13 PM How To Identify Stroke Threatening Plaques In Asymptomatic Patients By Contrast Duplex Or Biochemical Markers (Alpha NT pro BNP)
 
12:14 PM - 12:18 PM The Value Of Pre-Procedure CTA To Improve The Outcomes Of CAS
 
12:19 PM - 12:23 PM Restenosis After CAS Is Equal To That After CEA Based On Long-Term Results In 1,000 Patients
 
12:24 PM - 12:28 PM Transcervical CAS With Flow Reversal Eliminates Emboli During CAS: Why Does It Work And What Are The Adverse Event Rates With This Approach?
 
12:29 PM - 12:33 PM Outcomes After CEA: Is There A High Risk Population And Does This Have A Bearing On Some Of The CAS Trials Such As SAPPHIRE?
  Presenters(s):Richard P. Cambria, MD  
12:34 PM - 12:45 PM Panel Discussion
Refreshments Available
END OF SESSION 42
 
SESSION 43 SCHEDULE
Sunday
SESSION 43: NEW CONCEPTS, ADVANCES, LATE BREAKING INFORMATION (5-MINUTE TALKS)
xxxx
Moderators:TBD
x
12:45 PM - 12:50 PM Debate 24: Transcranial Doppler During CAS: When And Why Is Flow Reversal With The Gore-Parodi Device Better?
 
12:51 PM - 12:56 PM Debate 24: Why Flow Cessation During CAS (With The MOMA Device) Is Better: The ARMOUR Trial
 
12:57 PM - 1:02 PM Update On Results From The ACT Trial Comparing CEA And CAS With Protection In Asymptomatic Patients With Carotid Stenosis
 
1:03 PM - 1:08 PM Tips And Tricks To Allow Large Sheath Access For TEVAR And EVAR: Alternatives To External Conduits When Iliac Arteries Are Too Small Or Diseased To Allow Femoral Access
 
1:09 PM - 1:14 PM Noninvasive Treatment For CLI With A Sequential Compression Device: Does It Work?
 
1:15 PM - 1:20 PM What Are The Results And Complications With The TAG Endograft When It Is Used More Widely And Not Only In Centers Of Excellence (The Post Marketing Approval Trial)?
 
1:21 PM - 1:26 PM Treatment Of Iliac Aneurysms By Off-Label Modified Use Of Reversed ZENITH Limb Extensions: Technical Tips
 
1:27 PM - 1:32 PM What Is The Value Of C-Arm CT Scanning In EVAR Procedures And Patients?
  Presenters(s):Matt M. Thompson, MD  
1:33 PM - 1:38 PM The NELLIX Sac Anchoring Endoprosthesis For AAA Exclusion: A New Concept For EVAR
 
1:39 PM - 1:44 PM Advantages To 3-D Imaging (With M2S, TeraRecon, Or 3-Mensio) In Planning For Standard Infrarenal EVAR Procedures
 
1:45 PM - 1:53 PM Panel Discussion
END OF SESSION 43
 
SESSION 44 SCHEDULE
Sunday
SESSION 44: NEW CONCEPTS, ADVANCES AND LATE BREAKING INFORMATION (5-MINUTE TALKS)
xxxx
Moderators:TBD
x
1:53 PM - 1:58 PM New Developments In The Treatment Of Fibromuscular Dysplasia
 
1:59 PM - 2:04 PM When To Stent Renal Artery Stenosis With EVAR And What To Do For Restenosis
 
2:05 PM - 2:10 PM HYPERMED Camera For Measuring Cutaneous O2 Saturation Before And After Intervention: How Does It Help?
 
2:11 PM - 2:16 PM Cutting Balloon Facilitates CAS With Very Calcified Plaques: What Are The Dangers?
 
2:17 PM - 2:22 PM CAS Is Appropriate In Asymptomatic Patients But Not In Symptomatic Patients: CMS Has It Wrong
 
2:23 PM - 2:28 PM Endografts Can Serve As A Bridge To Definitive Repair: When And How Can This Be Helpful?
 
2:29 PM - 2:34 PM Lower Extremity Arterial Flow Is Decreased In Patients With Venous Disease: Why Does It Matter?
 
2:35 PM - 2:40 PM EVAR Without Contrast Is Safe: How To Do It
 
2:41 PM - 2:46 PM Covered Stents Will Improve Treatment For Renal Artery Stenosis
 
2:47 PM - 2:52 PM Cerebral Hyperfusion Syndrome Is Not What You Think: We Have Been Misled
 
2:53 PM - 3:00 PM Panel Discussion
3:00 PM - 3:05 PM Raffle Prize Drawing for fully paid, clinician attendees. You must be present to win.
3:05 PM - 3:05 PM Symposium Ends
END OF SESSION 44